HUMANA INC Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
HUMANA INC (HUM) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of $1.18 billion for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-04-29
- HUMANA INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $1.18B, a 4.67% decline year-over-year.
- HUMANA INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$776.00M.
- HUMANA INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $194.00M, a 59.58% decline year-over-year.
- HUMANA INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-06-30 was $543.00M, a 19.91% decline year-over-year.
- HUMANA INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was $1.20B, a 0.91% decline from fiscal 2024.
- HUMANA INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was $1.21B, a 51.13% decline from fiscal 2023.
- HUMANA INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was $2.48B, a 11.35% decline from fiscal 2022.
- HUMANA INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was $2.80B, a 4.50% decline from fiscal 2021.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-03-31 | $1.18B 10-Q · filed 2026-04-29 | $408.00M derived: sum of 2 quarters · filed 2026-04-29 | $602.00M derived: sum of 3 quarters · filed 2026-04-29 | $1.15B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | -$776.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$582.00M derived: sum of 2 quarters · filed 2026-02-19 | -$39.00M derived: sum of 3 quarters · filed 2026-02-19 | $1.20B 10-K · filed 2026-02-19 |
| 2025-09-30 | $194.00M 10-Q · filed 2025-11-05 | $737.00M derived: sum of 2 quarters · filed 2025-11-05 | $1.98B 10-Q · filed 2025-11-05 | $1.30B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $543.00M 10-Q · filed 2025-07-30 | $1.78B 10-Q · filed 2025-07-30 | $1.10B derived: sum of 3 quarters · filed 2026-04-29 | $1.58B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $1.24B 10-Q · filed 2026-04-29 | $559.00M derived: sum of 2 quarters · filed 2026-04-29 | $1.04B derived: sum of 3 quarters · filed 2026-04-29 | $1.72B derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | -$683.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$203.00M derived: sum of 2 quarters · filed 2026-02-19 | $475.00M derived: sum of 3 quarters · filed 2026-02-19 | $1.21B 10-K · filed 2026-02-19 |
| 2024-09-30 | $480.00M 10-Q · filed 2025-11-05 | $1.16B derived: sum of 2 quarters · filed 2025-11-05 | $1.90B 10-Q · filed 2025-11-05 | $1.36B derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $678.00M 10-Q · filed 2025-07-30 | $1.42B 10-Q · filed 2025-07-30 | $877.00M derived: sum of 3 quarters · filed 2026-02-19 | $1.71B derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $739.00M 10-Q · filed 2025-04-30 | $199.00M derived: sum of 2 quarters · filed 2026-02-19 | $1.03B derived: sum of 3 quarters · filed 2026-02-19 | $1.99B derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$540.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $290.00M derived: sum of 2 quarters · filed 2026-02-19 | $1.25B derived: sum of 3 quarters · filed 2026-02-19 | $2.48B 10-K · filed 2026-02-19 |
| 2023-09-30 | $830.00M 10-Q · filed 2024-10-30 | $1.79B derived: sum of 2 quarters · filed 2024-10-30 | $3.02B 10-Q · filed 2024-10-30 | $3.01B derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $956.00M 10-Q · filed 2024-07-31 | $2.19B 10-Q · filed 2024-07-31 | $2.18B derived: sum of 3 quarters · filed 2025-02-20 | $3.37B derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $1.24B 10-Q · filed 2024-04-24 | $1.22B derived: sum of 2 quarters · filed 2025-02-20 | $2.41B derived: sum of 3 quarters · filed 2025-02-20 | $3.11B derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | -$18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $1.18B derived: sum of 2 quarters · filed 2025-02-20 | $1.87B derived: sum of 3 quarters · filed 2025-02-20 | $2.80B 10-K · filed 2025-02-20 |
| 2022-09-30 | $1.19B 10-Q · filed 2023-11-01 | $1.89B derived: sum of 2 quarters · filed 2023-11-01 | $2.82B 10-Q · filed 2023-11-01 | $2.81B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $697.00M 10-Q · filed 2023-08-02 | $1.63B 10-Q · filed 2023-08-02 | $1.61B derived: sum of 3 quarters · filed 2024-02-15 | $3.15B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $930.00M 10-Q · filed 2023-04-26 | $917.00M derived: sum of 2 quarters · filed 2024-02-15 | $2.45B derived: sum of 3 quarters · filed 2024-02-15 | $3.04B derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | -$13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $1.52B derived: sum of 2 quarters · filed 2024-02-15 | $2.11B derived: sum of 3 quarters · filed 2024-02-15 | $2.93B 10-K · filed 2024-02-15 |
| 2021-09-30 | $1.53B 10-Q · filed 2022-11-02 | $2.12B derived: sum of 2 quarters · filed 2022-11-02 | $2.95B 10-Q · filed 2022-11-02 | $2.67B derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $588.00M 10-Q · filed 2022-07-27 | $1.42B 10-Q · filed 2022-07-27 | $1.14B derived: sum of 3 quarters · filed 2023-02-16 | $2.48B derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $828.00M 10-Q · filed 2022-04-27 | $554.00M derived: sum of 2 quarters · filed 2023-02-16 | $1.89B derived: sum of 3 quarters · filed 2023-02-16 | |
| 2020-12-31 | -$274.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $1.07B derived: sum of 2 quarters · filed 2023-02-16 | $3.37B 10-K · filed 2023-02-16 | |
| 2020-09-30 | $1.34B 10-Q · filed 2021-11-03 | $3.64B 10-Q · filed 2021-11-03 | ||
| 2019-12-31 | $2.71B 10-K · filed 2022-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |